GUFICBIO.NSGUFICBIO.NSNSE
Loading
EBITDA Over TimeStrong
Percentile Rank73
3Y CAGR-0.8%
5Y CAGR+9.3%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-0.8%/yr
vs +28.7%/yr prior
5Y CAGR
+9.3%/yr
Recent deceleration
Acceleration
-29.5pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$1.34B-3.2%
2025$1.38B-6.6%
2024$1.48B+7.9%
2023$1.37B-7.6%
2022$1.48B+73.1%
2021$857.85M+51.4%
2020$566.70M+13.3%
2019$500.22M+15.0%
2018$435.03M+79.3%
2017$242.66M-